BioCentury | Oct 3, 2018
Distillery Therapeutics

Infectious disease

...by Novartis AG could include testing the compound in additional animal models of bacterial infection. A2A Pharmaceuticals LLC...
BioCentury | Jul 20, 2018
Company News

Insilico, A2A launch Consortium.AI to develop candidates for rare orphan diseases

...Insilico Medicine Inc. (Baltimore, Md.) and A2A Pharmaceuticals LLC (Chappaqua, N.Y.) partnered to launch Consortium.AI, a company that...
...of Johnson & Johnson (NYSE:JNJ). A2A Pharmaceuticals LLC, Chappaqua, N.Y. Insilico Medicine Inc., Baltimore, Md. Business: Musculoskeletal Allison Johnson A2A Pharmaceuticals LLC Insilico...
BioCentury | Jun 1, 2018
Emerging Company Profile

Scratching the surface

...its platform to develop molecules with bactericidal activity against Gram-negative bacteria. At least two companies, A2A Pharmaceuticals LLC...
...$199,851) Investors: Undisclosed angel investors CEO: Ajay Mistry Patents: None issued Companies and Institutions Mentioned A2A Pharmaceuticals LLC...
BioCentury | Jun 20, 2017
Distillery Therapeutics

Infectious disease

...AG could include testing the safety and PK/PD of the compound in the infection models. A2A Pharmaceuticals LLC...
BioCentury | Apr 28, 2017
Finance

1Q17 public-private partnership roundup

...the end of 2019. At least two other companies have LpxC inhibitors in preclinical development: A2A Pharmaceuticals LLC...
...has licensed the synthetic pox virus from the University of Alberta. Companies and Institutions Mentioned A2A Pharmaceuticals LLC...
...U.K. Targets LpxC - UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase Mark Zipkin and Winnie Pong, Staff Writers ACAM2000 ALVAC HIV vaccine Alvac-HIV CD201 HVTN 100 TNX-801 VIS705 A2A Pharmaceuticals LLC Achaogen...
BioCentury | Aug 22, 2016
Emerging Company Profile

Metal smithing

...hours in a mouse model of wild-type E. coli infection. At least one other company, A2A Pharmaceuticals LLC...
...its own IP covering the LpxC program and its cancer programs. Companies and Institutions Mentioned A2A Pharmaceuticals LLC...
Items per page:
1 - 6 of 6
BioCentury | Oct 3, 2018
Distillery Therapeutics

Infectious disease

...by Novartis AG could include testing the compound in additional animal models of bacterial infection. A2A Pharmaceuticals LLC...
BioCentury | Jul 20, 2018
Company News

Insilico, A2A launch Consortium.AI to develop candidates for rare orphan diseases

...Insilico Medicine Inc. (Baltimore, Md.) and A2A Pharmaceuticals LLC (Chappaqua, N.Y.) partnered to launch Consortium.AI, a company that...
...of Johnson & Johnson (NYSE:JNJ). A2A Pharmaceuticals LLC, Chappaqua, N.Y. Insilico Medicine Inc., Baltimore, Md. Business: Musculoskeletal Allison Johnson A2A Pharmaceuticals LLC Insilico...
BioCentury | Jun 1, 2018
Emerging Company Profile

Scratching the surface

...its platform to develop molecules with bactericidal activity against Gram-negative bacteria. At least two companies, A2A Pharmaceuticals LLC...
...$199,851) Investors: Undisclosed angel investors CEO: Ajay Mistry Patents: None issued Companies and Institutions Mentioned A2A Pharmaceuticals LLC...
BioCentury | Jun 20, 2017
Distillery Therapeutics

Infectious disease

...AG could include testing the safety and PK/PD of the compound in the infection models. A2A Pharmaceuticals LLC...
BioCentury | Apr 28, 2017
Finance

1Q17 public-private partnership roundup

...the end of 2019. At least two other companies have LpxC inhibitors in preclinical development: A2A Pharmaceuticals LLC...
...has licensed the synthetic pox virus from the University of Alberta. Companies and Institutions Mentioned A2A Pharmaceuticals LLC...
...U.K. Targets LpxC - UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase Mark Zipkin and Winnie Pong, Staff Writers ACAM2000 ALVAC HIV vaccine Alvac-HIV CD201 HVTN 100 TNX-801 VIS705 A2A Pharmaceuticals LLC Achaogen...
BioCentury | Aug 22, 2016
Emerging Company Profile

Metal smithing

...hours in a mouse model of wild-type E. coli infection. At least one other company, A2A Pharmaceuticals LLC...
...its own IP covering the LpxC program and its cancer programs. Companies and Institutions Mentioned A2A Pharmaceuticals LLC...
Items per page:
1 - 6 of 6